Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Genmark Diagnostics (GNMK)

Genmark Diagnostics (GNMK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,756,987
  • Shares Outstanding, K 73,086
  • Annual Sales, $ 171,550 K
  • Annual Income, $ -18,640 K
  • 60-Month Beta 3.05
  • Price/Sales 10.24
  • Price/Cash Flow N/A
  • Price/Book 18.30
Trade GNMK with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.21
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/03/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview

Details
  • Implied Volatility 0.00%
  • Historical Volatility 6.71%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.06
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.84 +0.82%
on 04/12/21
24.25 -0.87%
on 03/26/21
unch (unch)
since 03/19/21
3-Month
12.76 +88.40%
on 01/29/21
24.25 -0.87%
on 03/26/21
+9.40 (+64.21%)
since 01/21/21
52-Week
8.42 +185.51%
on 04/22/20
24.25 -0.87%
on 03/26/21
+15.65 (+186.53%)
since 04/21/20

Most Recent Stories

More News
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Sector ETF report for XHE

XHE : 129.47 (+1.04%)
GNMK : 24.04 (unch)
PEN : 265.80 (+1.41%)
IHI : 63.31 (+0.54%)
NARI : 90.08 (+0.43%)
Navigating the Choppy Waters of Implementing Rapid Molecular Blood Culture Identification Tests, Upcoming Webinar Hosted by Xtalks

, /PRNewswire-PRWeb/ -- The implementation process for rapid molecular blood culture identification can be a complex process for laboratories, medical staff and the antimicrobial stewardship program...

GNMK : 24.04 (unch)
Roche purchases shares in tender offer for GenMark Diagnostics, Inc.

Basel, 22 April 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and GenMark Diagnostics, Inc. today announced that Roche's wholly owned subsidiary Geronimo Acquisition Corp. has accepted for payment all shares...

GNMK : 24.04 (unch)
SHAREHOLDER ALERT: WeissLaw LLP Reminds STAY, GNMK, LDKB, and PBCT Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

STAY : 20.46 (unch)
GNMK : 24.04 (unch)
LDKB : 18.2000 (+2.25%)
PBCT : 15.84 (-0.56%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates LMNX, NUAN, CADE, GNMK; Shareholders are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

LMNX : 36.99 (+0.03%)
NUAN : 54.93 (-0.13%)
CADE : 19.31 (+1.47%)
GNMK : 24.04 (unch)
SHAREHOLDER ALERT: WeissLaw LLP Reminds GNMK, LDKB, PBCT, and CTB Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

LDKB : 18.2000 (+2.25%)
GNMK : 24.04 (unch)
PBCT : 15.84 (-0.56%)
CTB : 60.17 (-0.05%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CLGX, KSHB, AEGN, GNMK; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / April 12, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

CLGX : 80.00 (+0.59%)
KSHB : 0.9055 (+2.32%)
AEGN : 29.99 (-0.03%)
GNMK : 24.04 (unch)
STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

NEW YORK, NY / ACCESSWIRE / April 9, 2021 / , founder and managing partner at , a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered...

CTB : 60.17 (-0.05%)
CUB : 75.00 (+0.32%)
GNMK : 24.04 (unch)
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Leaf Group Ltd. (NYSE - LEAF), GenMark Diagnostics (Nasdaq - GNMK), Houston Wire & Cable Company (Nasdaq - HWCC)

BALA CYNWYD, PA / ACCESSWIRE / April 7, 2021 / Brodsky & Smith, LLC reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other...

LEAF : 8.49 (unch)
GNMK : 24.04 (unch)
HWCC : 5.30 (+0.19%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds RMBL, STAY, GNMK, and SLGG Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

RMBL : 38.60 (+0.84%)
STAY : 20.46 (unch)
GNMK : 24.04 (unch)
SLGG : 4.33 (-1.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor' XT-8 system is the second generation in GenMark Dx's eSensor' platform, utilizing electrochemical detection technology to detect nucleic...

See More

Key Turning Points

3rd Resistance Point 24.09
2nd Resistance Point 24.07
1st Resistance Point 24.06
Last Price 24.04
1st Support Level 24.03
2nd Support Level 24.01
3rd Support Level 24.00

See More

52-Week High 24.25
Last Price 24.04
Fibonacci 61.8% 18.20
Fibonacci 50% 16.33
Fibonacci 38.2% 14.47
52-Week Low 8.42

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar